Purchase Order 75F40122P00547
Award Date 9/26/22
Potential Completion Date 9/29/27
Potential Value $89K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Beltsville, MD 20704, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Kemp Proteins, LLC, doing business as Kempbio, has been awarded a $119,790 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide gene synthesis, cloning, and plasmid generation services. The contract has a period of performance from August 10, 2023 through December 31, 2023. The services will be delivered at Kempbio's place of performance in Frederick, Maryland and will support the NIH/NIAID's research efforts...
- The Food and Drug Administration awarded a purchase order to Animal Specialties And Provisions South, LLC, a woman-owned small disadvantaged business, for $1,659,151.44 in animal feed and bedding supplies, with an award date of May 3, 2024 and ultimate completion date of May 5, 2029. Work is performed in Hanover, Maryland. The requirement covers annual supplies of animal feed, bedding, and related products to support research activities at the Center for Biologics Evaluation and Research. The...
- The Food and Drug Administration awarded a firm fixed-price purchase order to PAK Biosolutions, Inc., a woman-owned small business, for an Integrated Continuous Purification System valued at $504,772.00, with an award date of September 25, 2022. The order carries a total small business set-aside designation. Performance will be completed in Silver Spring, Maryland, with an ultimate completion date of February 22, 2028. PAK Biosolutions manufactures biopharmaceutical purification and continuous...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $20,940.38 delivery order contract to Biomerieux, Inc. for supplies. The prime contractor Biomerieux, Inc. will perform the work at its Calverton, Maryland facility. The firm fixed price contract runs from May 18, 2022 through July 28, 2026. No additional details were provided regarding the specific supplies requested under the original solicitation. The HHS FDA regulates food and drugs to ensure...
- The Food and Drug Administration awarded a purchase order to Aptagen LLC for $100,000.00 on September 27, 2024, for development of Amb a 1-specific aptamers for use in enzyme-linked immunosorbent assay and immunoenzymometric assay protocols to measure biological potency of commercial ragweed pollen extracts. Work is performed in Jacobus, Pennsylvania. The order carries a total small business set-aside and concludes September 26, 2025. The originating solicitation, posted September 19, 2024...
- <p>The Food and Drug Administration issued a purchase order to Government Scientific Source Inc., a small business, for Luminex magnetic carboxylated microsphere beads on June 26, 2026, with a ceiling value of $34,850.00. Performance will be completed by August 26, 2026, at the contractor's location in Reston, Virginia. The order is firm fixed price with no set-aside designation.</p>
- The Defense Department's Medical Supply Chain issued a delivery order to Government Scientific Source Inc. on March 10, 2026, for FBS (Fetal Bovine Serum) characterized US 500 mL with a ceiling value of $26,272.24. The order is issued under a fixed-price contract with economic price adjustment. Place of performance is Reston, VA. Ultimate completion is March 31, 2026. Government Scientific Source Inc. is a for-profit small business specializing in laboratory products, scientific equipment,...
- <p>The Food and Drug Administration awarded a purchase order to University of Maryland, Baltimore on September 7, 2022, for RNA extraction, quality control assessment, library preparation, and Illumina sequencing of 200 peripheral blood samples collected in Paxgene tubes, with a ceiling value of $54,999.98 and completion date of September 29, 2023. Work is performed in Baltimore, Maryland. The order carries no set-aside designation and is priced on a firm fixed price basis.</p>
- <p>The Bureau of Medicine and Surgery awarded a purchase order to Belomed S.R.L. for $8,714.00 on April 9, 2026, for laboratory supplies including Blocker BSA, One Step Ultra TMB ELISA substrate solution, Schneiders Drosophila medium, and fetal bovine serum (heat inactivated). Belomed S.R.L. is a minority-owned organization based in Peru. Performance is located in Peru, with completion required by September 30, 2026. The order carries firm fixed-price terms and no set-aside designation.</p>
- The Food and Drug Administration awarded a delivery order valued at $266,359.20 to Mcneal Professional Services, Inc., a women-owned small business headquartered in Kennesaw, Georgia, for a Biologist I position. The contract, awarded on June 23, 2020, with completion targeted for July 9, 2022, is set aside for total small business and carries firm fixed-price pricing. Performance will take place at the FDA's Silver Spring, Maryland facility. Mcneal Professional Services holds SBA certification...
The Food and Drug Administration awarded a purchase order to Kemp Proteins, LLC (doing business as Kempbio), a small disadvantaged business, for $89,239.94 on September 26, 2022. The order carries a total small business set-aside designation. Performance is located in Beltsville, Maryland, with work extending through September 29, 2027. The purchase order covers monoclonal antibody production services. The solicitation was posted September 1, 2022, with a due date of September 13, 2022.
Generated 6/12/26, 10:55 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Monoclonal Antibody Production | FDA-RFQ-1255308 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 9/1/22, 6:33 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $17.3k | 8/11/23 | |
| Not listed | Not listed | $16.8k | 9/25/22 |